Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2019-11-19 Regulatory Filings
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2019
Regulatory Filings Classification · 100% confidence The document is titled 'Orphazyme receives Breakthrough Therapy Designation for arimoclomol in Niemann-Pick Disease Type C (NPC)' and is explicitly labeled as a 'Company announcement' dated November 19, 2019. It details a specific regulatory event (FDA granting Breakthrough Therapy Designation) concerning an investigational drug. This type of announcement, which communicates a significant, non-financial operational or regulatory milestone, fits best under the general 'Regulatory Filings' category (RNS) as it is not a standard financial report (10-K, IR, ER) or a specific management/board change (MANG, DIRS). It is a direct regulatory update, but since RNS is the catch-all for general regulatory announcements not covered by other specific codes, it is the most appropriate fit among the provided options for a press release about a drug designation.
2019-11-19 English
Major shareholder announcement
Major Shareholding Notification Classification · 100% confidence The document is a formal notification from Orphazyme A/S regarding a change in shareholding by Danske Bank A/S, specifically citing Section 38 of the Danish Capital Markets Act. This is a standard disclosure of a major shareholder crossing a reporting threshold, which falls under the 'Major Shareholding Notification' category.
2019-10-02 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 100% confidence The document is explicitly titled "Major shareholder announcement" and details a notification received pursuant to Section 38 of the Danish Capital Markets Act regarding a change in shareholding percentage (crossing the 5% threshold) by Danske Bank A/S. This directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ' in the provided schema.
2019-10-02 English
Orphazyme announces Interim Report First Half 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report First Half 2019' for Orphazyme A/S. It contains comprehensive financial statements (income statement, balance sheet, cash flow), management's discussion and analysis of financial results, business highlights, and operational updates for the six-month period ending June 30, 2019. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2019
2019-08-28 English
Orphazyme announces Interim Report First Half 2019
Report Publication Announcement Classification · 95% confidence The document is a short company announcement (under 8,700 characters) that summarizes key highlights and financial results for the first half of 2019. Crucially, it explicitly lists the 'Interim Report First Half 2019' as an attachment at the end of the text. According to the 'Menu vs Meal' rule, this document serves as an announcement of the report rather than the full report itself, making it a Report Publication Announcement (RPA). H1 2019
2019-08-28 English
Report Publication Announcement 2019
Report Publication Announcement Classification · 95% confidence The document is an announcement from Orphazyme A/S regarding their interim financial results for the first half of 2019. While it contains summary financial data (net loss, R&D expenses, cash position), it is structured as a press release/company announcement (No. 26/2019) rather than the full interim report itself. It provides highlights and invites investors to a conference call to discuss the report. According to the 'Menu vs Meal' rule, this is an announcement of a report, which falls under the Report Publication Announcement (RPA) category. H1 2019
2019-08-28 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.